FDA clears convalescent plasma treatment for COVID-19


Washington – The Food and Drug Administration announced on Sunday that it had authorized an emergency use statement for convalescent plasma to be treated the coronavirus. FDA Commissioner Dr Stephen Hahn said early trials indicate a 35% better chance of survival when convalescent plasma is used in “optimal patients.”President Trump held a press conference with Hahn at the White House shortly after the FDA announced the emergency clearance. The two left as several reporters shouted “Was there any pressure on you to allow this? ”

CBS News’ Weijia Jiang reported last week that the director of the National Institute of Health, Dr Francis Collins, the director of the National Institute of Allergy and Infectious Diseases, Dr Anthony Fauci and other members NIH warned Hahn against approving the emergency use authorization.


Please enter your comment!
Please enter your name here